DELAWARE STATE SENATE

152nd GENERAL ASSEMBLY

SENATE CONCURRENT RESOLUTION NO. 52

DESIGNATING THE MONTH OF MAY 2023 AS "LUPUS AWARENESS MONTH" IN THE STATE OF DELAWARE.

WHEREAS, lupus (systemic lupus erythematosus) is a chronic autoimmune disease that causes the immune system to attack its own tissues, and affects the skin, joints, heart, lung, kidneys, blood cells, and brain; and 

WHEREAS, an estimated 1.5 million Americans, and 5 million individuals worldwide, have a form of lupus; and 

WHEREAS, females are nine times more likely to have lupus than males, and lupus is more prevalent among people of color than white individuals; and 

WHEREAS, 1 in 3 lupus patients suffer from multiple autoimmune diseases; and 

WHEREAS, the cause of lupus is unknown, and there is no known cure; and 

WHEREAS, it is believed that between 10 and 15 percent of people with lupus will die prematurely due to complications of lupus, but, due to improved diagnosis and disease management, most people with the disease will go on to live a normal lifespan; and 

WHEREAS, the month of May has been recognized as National Lupus Awareness Month. 

NOW, THEREFORE:

BE IT RESOLVED by the Senate of the 152nd General Assembly of the State of Delaware, the House of Representatives concurring therein, that the Legislature affirms the importance of Lupus awareness, and hereby designates May 2023 as “Lupus Awareness Month” in the State of Delaware. 

BE IT FURTHER RESOLVED that the General Assembly encourages expanded efforts to keep Delaware residents properly informed about Lupus symptom recognition and treatment.

SYNOPSIS

This concurrent resolution designates May 2023 as "Lupus Awareness Month" in the State of Delaware and encourages expanded efforts to keep Delaware residents properly informed about Lupus symptom recognition and treatment.

Author: Senator Hoffner